Patient-led appointment scheduling in NHS Talking Therapies

Using patient-led appointment scheduling to improve cost-effectiveness, access, and patient satisfaction in NHS Talking Therapies services: A feasibility study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN76380818

Enrollment

Registered

2025-04-10

Start date

2025-07-09

Completion date

Unknown

Last updated

2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Specialty: Mental Health, Primary sub-specialty: Service evaluations - service users

Interventions

This project will use a mixed-methods design comprising four work packages (WPs). WP1: Stakeholder workshops Our initial stakeholder work and key NHS policy documents (NHS England, 2019

NHS England & NHS Improvement, 2019) suggest that making PLAS accessible to people from a variety of backgrounds should be a priority. We aim to draw on the expertise of relevant stakeholders to co-ad

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Referred to NHS Talking Therapies for low-intensity psychological interventions 2. Attended an initial appointment and assessed as requiring one-to-one psychological interventions with a Psychological Wellbeing Practitioner delivered at Step 2 of NHS Talking Therapies 3. Aged > = 18 years or older 4. Has capacity to provide informed consent

Exclusion criteria

Exclusion criteria: Participants not meeting the participant inclusion criteria

Design outcomes

Primary

Measure	Time frame
1.Depression severity is measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline, 6 months, and 9 months. 2.Generalised anxiety disorder severity is measured using the Generalised Anxiety Disorder-7 (GAD-7) at baseline, 6 months, and 9 months. 3.The impact of mental health difficulties on different dimensions of social functioning is measured using the Work and Social Adjustment Scale (WSAS) at baseline, 6 months, and 9 months. 4.Patient experience and satisfaction with service provision are measured with the Patient Experience Questionnaire (PEQ) at 6 months 5.Health outcomes are measured using the EuroQoL Five Dimension Five Level Version (EQ-5D-5L) at baseline, 6 months, and 9 months. 6.Data on participants’ use of healthcare resources in the preceding six months will be collected using a bespoke Resource Use Questionnaire (RUQ) at baseline, 6 months, and 9 months.	—

Measure

Time frame

1.Depression severity is measured using the Patient Health Questionnaire-9 (PHQ-9) at baseline, 6 months, and 9 months. 2.Generalised anxiety disorder severity is measured using the Generalised Anxiety Disorder-7 (GAD-7) at baseline, 6 months, and 9 months. 3.The impact of mental health difficulties on different dimensions of social functioning is measured using the Work and Social Adjustment Scale (WSAS) at baseline, 6 months, and 9 months. 4.Patient experience and satisfaction with service provision are measured with the Patient Experience Questionnaire (PEQ) at 6 months 5.Health outcomes are measured using the EuroQoL Five Dimension Five Level Version (EQ-5D-5L) at baseline, 6 months, and 9 months. 6.Data on participants’ use of healthcare resources in the preceding six months will be collected using a bespoke Resource Use Questionnaire (RUQ) at baseline, 6 months, and 9 months.

—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

England, United Kingdom

Contacts

Public ContactRobert Griffiths

Robert.griffiths-2@manchester.ac.uk-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 17, 2026